Untreated Patients with Multiple Sclerosis: Prevalence and Characteristics in Denmark and in the United States (P4.2-060)
Mette Nørgaard(Aarhus University Hospital), Meritxell Sabidó-Espin(Merck KGaA, Darmstadt (Germany)), Caroline Foch(Merck KGaA, Darmstadt (Germany)), Emmanuelle Boutmy(Merck KGaA, Darmstadt (Germany)), Per Soelberg Sørensen(University of Copenhagen), Finn Sellebjerg(Danish Multiple Sclerosis Center), Katalin Veres(Aarhus University Hospital), Melinda Magyari(University of Copenhagen)
Cited by 2
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|957